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Purpose: This paper reviews the research literature on text mining (TM) with the aim to
ﬁnd out (1) which cancer domains have been the subject of TM efforts, (2) which knowledge
resources can support TM of cancer-related information and (3) to what extent systems that
rely  on knowledge and computational methods can convert text data into useful clinical
information. These questions were used to determine the current state of the art in this
particular strand of TM and suggest future directions in TM development to support cancer
research.
Methods: A review of the research on TM of cancer-related information was carried out. A
literature search was conducted on the Medline database as well as IEEE Xplore and ACM
digital libraries to address the interdisciplinary nature of such research. The search results
were supplemented with the literature identiﬁed through Google Scholar.
Results: A range of studies have proven the feasibility of TM for extracting structured infor-
mation from clinical narratives such as those found in pathology or radiology reports. In this
article, we provide a critical overview of the current state of the art for TM related to cancer.
The  review highlighted a strong bias towards symbolic methods, e.g. named entity recog-
nition (NER) based on dictionary lookup and information extraction (IE) relying on pattern
matching. The F-measure of NER ranges between 80% and 90%, while that of IE for simple
tasks is in the high 90s. To further improve the performance, TM approaches need to deal
effectively with idiosyncrasies of the clinical sublanguage such as non-standard abbrevia-
tions as well as a high degree of spelling and grammatical errors. This requires a shift from
rule-based methods to machine learning following the success of similar trends in biological
applications of TM. Machine learning approaches require large training datasets, but clin-
ical  narratives are not readily available for TM research due to privacy and conﬁdentialityremaconcerns. This issue is  a need for a comprehen
of  textual information fou
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1.  Introduction
Around 325,000 people were diagnosed with cancer in 2010
in the UK (approximately 890 people per day) [1]. More than
1 in 3 people in the UK will develop some form of cancer
during their lifetime. Worldwide, around 12.7 million new
cases of cancer were estimated in 2008. Currently, half of
people diagnosed with cancer will survive for at least ﬁve
years. With constant advancements in cancer research and
healthcare provision, cancer survival rates in the UK have
doubled in the last 40 years. Still, cancer remains the most
common cause of death (29%) followed by circulatory diseases
(28%) such as heart disease and strokes [2]. Further advances
depend crucially on consistent and comparable data collec-
tion.
A wealth of relevant information exists in various types of
medical records, e.g. approximately 96% of cancer diagnoses
originate in the surgical pathology laboratory [3] and as such
they remain an important source for information to guide the
treatment of patients with cancer. Synoptic reports emerged
with the goal of structured data capture as means of improv-
ing the quality of data and collection methods. The College
of American Pathologists (CAP) as part of their contribution
to the International Collaboration on Cancer Reporting devel-
oped cancer checklists that prescribe collection of all critical
elements that should be reported for cancer specimens [4].
Still, in many  cases (e.g. colonoscopy) free-text reporting via
dictation is still the norm [5]. While synoptic reporting sys-
tems can effectively address structured data collection in the
future, it does not solve the problem of managing the legacy
data in free text format.
mining and machine learning (ML) to efﬁciently process large
document collections in order to support information retrieval
(which gathers and ﬁlters relevant documents), document
classiﬁcation (which maps documents to appropriate cate-
gories based on their content), information extraction (which
selects speciﬁc facts about pre-speciﬁed types of entities and
relationships of interest), terminology extraction (which col-
lects domain-relevant terms from a corpus of domain-speciﬁc
documents), named entity recognition (which identiﬁes enti-
ties from predeﬁned categories), etc.
A recent article provides a review of TM applications in can-
cer research [6]. It describes biomedical TM in general terms
and how it can be used in cancer systems biology. Systems
biology studies complex interactions in biological systems
such as gene regulatory networks, which are often explored
to provide insight into the cell proliferation observed in can-
cer. Therefore, most of the TM approaches discussed in the
mentioned review article focus on PubMed abstracts as the
richest source of text data on gene interactions and NLP tech-
niques to extract gene-related information. In this article, we
depart from biological applications of TM to focus primarily
on its clinical applications in the cancer domain. To address
the interdisciplinary nature of such research, we searched
the scientiﬁc literature encompassing the following areas:
biomedicine, life sciences, engineering, technology, comput-
ing and information technology. We relied on three literature
databases: Medline, IEEE Xplore and ACM digital libraries.
The search results were supplemented with the literature
identiﬁed through Google Scholar. The search terms included
cancer and related terms (e.g. carcinoma,  neoplasm, malignancy,
etc.) in combination with terminology related to text miningText mining (TM) has emerged as a potential solution for
bridging the gap between free-text and structured represen-
tation of cancer information. It uses techniques from natural
language processing (NLP), knowledge management, data(e.g. natural language processing,  information retrieval, information
extraction, etc.). To be included in the review, the citations were
required to discuss text mining of cancer-related information
demonstrated on or directly applicable to clinical narratives,
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Table 1 – Examples of text mining studies by cancer
domain.
Neoplasm by site CUI Study
Breast neoplasm C1458155 [14–21]
Cervical neoplasm C0007873 [22]
Colon neoplasm C0009375 [23,24]
Colorectal neoplasm C0009404 [5,25–30]
Lung neoplasm C0024121 [26,31,32]
Ovarian neoplasm C0919267 [33]
both resources are accessible via the UMLS Terminology Ser-ig. 1 – Text mining framework for clinical applications.
hich was determined by manually screening the full text of
etrieved publications.
Fig. 1 presents the general framework in which TM is used
n the clinical setting. Different types of cancer (e.g. breast
ancer) will deﬁne a speciﬁc domain in which TM is used. It
ill determine the choice of available text data (e.g. mammog-
aphy reports). Data interpretation, either by human experts
r computers, naturally requires relevant knowledge in a
iven domain. Machine readable representations of relevant
nowledge can be found in generic knowledge representation
ystems (e.g. UMLS [7]), specialised databases (e.g. BCGD [8]),
eporting guidelines (e.g. BI-RADS [9]), etc. Specialised TM soft-
are systems are then used to extract information (e.g. cancer
tage) as a joint function of data and knowledge. Extracted
nformation can further support various applications includ-
ng clinical research (e.g. epidemiology) and decision making
e.g. the choice of appropriate treatment). Before automati-
ally extracted information can be used in clinical setting, its
eliability needs to be validated. Analogously to establishing
he validity of diagnostic tests, TM systems are evaluated in
erms of a range of measures such as positive and negative
redictive value to determine to what extent the extracted
nformation corresponds to the reality represented by the
round truth.
The TM framework given in Fig. 1 has been used to provide a
tructure of this review. In Section 2, we discuss which cancer
omains have been the subject of TM efforts and which ones
ould be suitable targets of TM research in the near future.
 speciﬁc cancer domain will constrain the types of avail-
ble text data, which are discussed in Section 3. The available
nowledge resources that can support TM of cancer-related
nformation are summarised in Section 4. Section 5 describes
M systems that rely on knowledge and computational meth-
ds to convert text data into useful clinical information. To
scertain the feasibility of using TM to extract different types
f cancer-related information, this section also features the
eans of formally evaluating TM systems. The presentedPancreatic neoplasm C0030297 [34]
Prostate neoplasm C0033578 [21,26,35–37]
Skin neoplasm C0037286 [36]
systems are discussed in the context of their applications.
Finally, we conclude the paper with a discussion of the current
state of the art in this particular strand of TM and sug-
gest future directions in TM development to support cancer
research.
2.  Cancer  domains
Cancer is an umbrella term for diseases characterised by
excessive cellular division and proliferation. Cancer is no
longer viewed as a single disease or even a single collection
of diseases. Cancer may start developing in any of over 60
body organs and is usually named after the affected organ
(e.g. breast cancer). Each organ consists of different cell types
that may be affected by cancer, so several cancer types may
affect each organ (e.g. ductal carcinoma and lobular carci-
noma are different types of breast cancer). There are more
than 200 types of cancer having different causes, symptoms
and treatments. Therefore, cancer as a term covers a diverse
set of diseases, which are differentiated by a growing set of
biomarkers. Naturally, different types of information will be
reported for different types of cancer, so it may be expected
that TM approaches to processing text data in different cancer
domains will vary as well. Nonetheless, it would be useful to
know what knowledge and software resources can be re-used
in a speciﬁc domain. We, therefore, provide a brief summary of
TM activities across different cancer types. Detailed informa-
tion about the actual approaches taken is provided in Section
5.
The literature review revealed that most of the articles
on TM for cancer have been annotated with a MeSH term
that identiﬁes neoplasms by anatomical site, where neoplasm
refers to autonomous tissue growth in which the malignancy
status has not been established and for which the transformed
cell type has not been speciﬁcally identiﬁed. Both NCI The-
saurus [10] and MeSH [11] organise neoplasms by anatomical
site. Uniﬁed Medical Language System (UMLS) [7] currently
integrates 168 vocabularies, including both NCI Thesaurus and
MeSH. We  therefore provide a unique concept identiﬁer (CUI)
in UMLS, from which cross-references can be obtained to both
of these sources. Information from these knowledge sources
can be used to obtain lexical information (e.g. synonyms) as
well as links to other related concepts. For practical purposes,vices [12] and BioPortal [13].
Table 1 provides the mappings of TM studies to particu-
lar cancer domains. Breast, lung, bowel and prostate cancers
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Table 2 – Examples of document types used in text
mining studies across different cancer types.
Cancer type Document type Study
Breast neoplasm Mammography reports [14,17–19]
Breast neoplasm Pathology reports [16,20,21]
Breast neoplasm PubMed abstracts [15]
Cervical neoplasm PubMed abstracts [22]
Colon neoplasm Pathology reports [23,24]
Colorectal neoplasm EMR notes [25,26,28,29]
Colorectal neoplasm Pathology reports [27]
Colorectal neoplasm Histopathology reports [30]
Colorectal neoplasm Colonoscopy reports [5]
Lung neoplasm Radiographic reports [31]
Lung neoplasm EMR [26]
Lung neoplasm Pathology reports [32]
Ovarian neoplasm GPRD records [33]
Pancreatic neoplasm PubMed abstracts, EMRs [34]
Prostate neoplasm Clinical records: all
available paper, electronic,
radiologic, radiation
therapy and pathology
records
[37]Fig. 2 – A hierarchy of medical reports.
together account for over half of all new cancers each year [1].
Not surprisingly, most TM efforts have concentrated on these
domains. While most common cancers have been covered,
others such as bladder neoplasm, endometrial neoplasm,
renal neoplasm and thyroid gland neoplasm still remain to be
explored by TM.  In addition, we have not identiﬁed any TM
studies related speciﬁcally to haematologic neoplasms (e.g.
leukaemia or lymphoma), which are located in the blood and
blood-forming tissue (i.e. the bone marrow and lymphatic tis-
sue).
3.  Data  sources
Cancer-related information is described in various types
of text documents including scientiﬁc literature, medical
records, web documents and those found in specialised
databases. In this section, we focus on different types of text
data used in TM studies to support cancer research. Most
research in biomedical TM,  including mining of cancer-related
information, has been conducted on scientiﬁc literature. The
availability of article abstracts via the PubMed database has
made them the most popular source (e.g. [38]). While PubMed
abstracts ensure the breadth of information that can be mined,
they do not provide for depth, i.e. more  detailed information
can only be found in the body of the article and some stud-
ies have explored this information space with TM (e.g. [34]).
Unfortunately, access restrictions limit the availability of full-
text articles. Additionally, unlike the abstracts available in a
single resource such as PubMed, which have a uniform for-
mat, full text articles will be in different formats, which poses
difﬁculties in their processing. PubMed Central is an attempt
to make full-text articles freely available in a uniform format,
but it currently has a limited coverage compared to PubMed.
In addition to literature, much information relevant to cancer
available in free text records in specialised databases has been
used in TM studies, e.g. AERS (Adverse Event Reporting Sys-
tem) [39], ClinicalTrials.gov [40] and HPV Sequence Database
[41].
In a clinical setting, cancer-related information can be
found in various types of medical reports. For the purposes of
TM,  we  focus on electronic medical records (EMRs) – electronic
documents that may describe demographic information, med-
ical history, medication and known allergies, laboratory test
results, radiology images, etc. Fig. 2 shows a hierarchy of med-
ical reports that have been used as data sources in TM forProstate neoplasm Pathology reports [21,36]
Prostate neoplasm EMR [26]
Skin neoplasm Pathology reports [36]
cancer. In particular, two types of reports are relevant for
recording cancer-related information: pathology and imaging
reports. A pathology report describes the results of examin-
ing cells and tissues under a microscope following a biopsy
or surgery [42]. It typically contains information about the
patient, a description of how cells look under the microscope
and a diagnosis. This information is then used by clinicians to
support decision making on appropriate treatment.
Imaging reports (or radiology reports) serve the same pur-
pose of conveying a specialist interpretation of images and
relate it to the patient’s signs and symptoms in order to
suggest diagnosis [43]. Depending on the type of imaging tech-
nique used, we  can further differentiate between different
subclasses of imaging reports each having its own reporting
standards or guidelines, e.g. X-ray imaging reports (includ-
ing chest radiography and mammography reports), computed
tomography (CT) scan reports and magnetic resonance imag-
ing (MRI) reports. Table 2 shows which types of reports have
been used in TM studies focusing on different cancer types.
Hospital discharge summaries may contain cancer-
related information among other health-related topics. An
anonymised data set was initially released for the i2b2 NLP
challenge [44] and it can be used for research purposes (e.g.
[37]). Finally, medical certiﬁcate of death is a document issued
by a medical practitioner explaining the cause of death. Can-
cer monitoring and prevention rely on timely notiﬁcation of
cancer-related events including deaths. Cancer Registries sys-
tematically collect such information, but they may lag behind
due to manual classiﬁcation of cancer from the free-text doc-
uments such as death certiﬁcates, which is complex and
time-consuming activity [45].
While cancer research stands to beneﬁt from automated
processing of EMRs, there are ethical and legal issues associ-
ated with their use as they contain private and conﬁdential
information [46]. Patient data cannot be used for TM pur-
poses without consent [47]. In the EU, Data Protection Directive
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ofﬁcially Directive 95/46/EC) [48] speciﬁes rules on using
nformation about individuals. In the USA, the Health Insur-
nce Portability and Accountability Act (HIPAA) [49] provides
he standard for using patient data in electronic format.
heir violations may incur legal responsibilities and penalties.
n principle, no patient data should be individually identi-
able. This applies to anonymous data (collected without
atient-identiﬁable information), anonymized data (patient-
dentiﬁable information is removed) and de-identiﬁed data
patient-identiﬁable information is encoded or encrypted) [50].
nfortunately, even when all reasonable measures to protect
rivacy and conﬁdentiality are taken (e.g. de-identiﬁcation
nd data use agreements), in most cases only researchers
ith local afﬁliation are allowed access [51]. This remains the
ain bottleneck, more  widely, for progress in healthcare appli-
ations of NLP. Most systems described in this review were
eveloped and evaluated on local data, which does not allow
or their direct comparison or for estimating how generalisable
heir methods are.
.  Knowledge  sources
o identify different cancer patient cohorts from their medical
ecords or obtain baseline classiﬁcation for automated meth-
ds, many  studies relied on the relevant coding systems used.
n the USA, billing data typically consists of codes derived from
he International Classiﬁcation of Diseases (ICD) and Current
rocedural Terminology (CPT) [52]. ICD is a taxonomy of dis-
ases, signs, symptoms and procedure codes maintained by
he World Health Organisation (WHO). For example, Coden
t al. used ICD-9-CM codes (153.x, 154.x) to select pathology
eports of patients diagnosed with colon cancer [23]. Sim-
larly, D’Avolio et al. used ICD-9 codes to select pathology
eports related to colorectal cancer (153.x, 154.x), prostate can-
er (185.x) and lung cancer (162.x) [26]. ICD version 9-CM is
n use in the USA (as of 2012), whereas the majority of other
ountries use ICD version 10. For example, Butt et al. relied
n death classiﬁcations based on ICD-9 and ICD-10 codes that
ccompany the death certiﬁcate reports in Australia [45]. More
etailed classiﬁcation of oncology information is available via
he International Classiﬁcation of Diseases – Oncology (ICD-O)
ersion 3, a domain-speciﬁc extension of ICD, which is consid-
red as the lingua franca of pathologists and is in widespread
se within tumour registries [23]. In PubMed, relevant liter-
ture can be selected using MeSH classiﬁcations [11]. Most
rticles relevant for cancer will be annotated with a term from
he Neoplasms (C04) section.
TM of cancer data requires understanding of the under-
ying terminology, which is described in the NCI Thesaurus
10], a reference terminology of the cancer domain. The NCI
hesaurus provides deﬁnitions and synonyms of nearly 10,000
ancers and related diseases, 8000 single agents and combina-
ion therapies and a range of other cancer-related topics. More
eneral clinical terminology can be found in SNOMED CT, the
ystematized Nomenclature of Medicine Clinical Terms [53].
Although available independently, most of the mentioned
esources are accessible via the UMLS Terminology Services
12] and BioPortal [13] (Table 3). Moreover, UMLS provides f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623 609
integration of these resources by linking the original
identiﬁers to a single designated concept.
BioPortal is a web portal that provides access to one of the
largest repositories of biomedical ontologies [60]. It provides
a uniform mechanism to access biomedical ontologies and
terminologies provided in different representation formats,
including OBO and OWL. The associated web services provide
programmatic access to these ontologies [61], which allows for
their easy integration into the TM framework. Tables 4 and 5
provide a list of ontologies from BioPortal that are directly or
indirectly related to cancer. In addition, one can deﬁne and
share their own cancer-speciﬁc ontology on BioPortal and take
advantage of its web services.
Other resources that can be used as a guideline as to how
to structure and report cancer information extracted from free
text are listed in Table 6. The College of American Patholo-
gist developed cancer checklists that prescribe collection of
all critical elements that should be reported for cancer spec-
imens [4]. These checklists provide templates for the types
of information a TM system should aim to extract from free-
text medical reports. Speciﬁcally, in the breast cancer domain
BI-RADS deﬁnes a hierarchy of terms to describe ﬁndings
in mammograms  together with mammography assessment
categories [9]. Classiﬁcation of ﬁndings in free-text medi-
cal reports requires more  complex text analysis as well as
domain-speciﬁc knowledge. In general, tumours are classi-
ﬁed using TNM (Tumour-Node-Metastases) classiﬁcation of
malignant tumours, an internationally agreed-upon standard
to describe and categorise cancer stages and progression [62].
It is based on the extent of the primary tumour (T), spread
to nearby lymph nodes (N) and distant metastasis (M). TNM
guidelines are cancer-speciﬁc.
In addition to formal knowledge resources, public web
sites may be helpful to TM developers to familiarise with the
domain. Table 7 provides a list of credible web sites.
5.  Text  data  processing
In this section we focus on speciﬁc text processing tasks
together with a review of methods and techniques used to
solve them in the cancer domain. We  differentiate between
four major NLP tasks: named entity recognition (NER), infor-
mation extraction (IE), text classiﬁcation and information
retrieval (IR). In order to assess the feasibility and compare
different approaches, we  ﬁrst describe how the systems sup-
porting these NLP tasks can be evaluated.
5.1.  Evaluation
Most NLP tasks can be viewed as classiﬁcation problems in
which, given an instance, the system predicts its class label.
For instance, an NER system in effect labels a phrase as a
named entity. Similarly, an IR system will classify a document
as relevant or irrelevant with respect to the user’s information
need. Various measures can be used to evaluate classiﬁ-
cation performance based on a confusion matrix, which
contains information about actual (or known) labels and
those predicted automatically by the system. Given a binary
classiﬁcation problem, there are four possible outcomes
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Table 3 – Examples of cancer-relevant vocabularies and classiﬁcation systems.
Vocabulary Body URL UMLS ID BioPortal ID Study
CPT AMA http://www.ama-assn.org/ama/pub/physician-
resources/solutions-managing-your-practice/
coding-billing-insurance/cpt.page?
CPT 1504 [20,52]
ICD-9 WHO [20,26,34,45]
ICD-9-CM WHO ICD9CM 1101 [23,52,54]
ICD-10 WHO http://www.who.int/classiﬁcations/icd/ ICD10 1516 [45]
ICD-10-CM WHO ICD10CM 1553 –
ICD-O-3 WHO http://www.who.int/classiﬁcations/icd/
adaptations/oncology/en/index.html
[23,24,55,56]
MedDRA ICH http://www.meddra.org/ MDR 1422 [39]
MeSH NLM http://www.nlm.nih.gov/mesh/ MSH 1351 [34,57–59]
NCI Thesaurus NCI http://ncit.nci.nih.gov/ NCI 1032 [60]
SNOMED CT IHTSDO http://www.ihtsdo.org/snomed-ct/ SNOMEDCT 1353 [21,26,27,30,32,45]
Abbreviations:  AMA, American Medical Association; ICH, International Conference on Harmonisation; IHTSDO, International Health Terminology
Standards Development Organisation; NCI, National Cancer Institute; NLM, National Library of Medicine; WHO, World Health Organisation.
Table 4 – Examples of cancer-speciﬁc ontologies.
Name Description BioPortal ID
Breast Cancer Grading
Ontology
Assigns a grade to a tumour starting from the three criteria of the
next generation sequencing.
1304
Cancer Chemoprevention
Ontology
Describes  and semantically interconnect the different paradigms of
the cancer chemoprevention domain.
3030
Cancer Research and
Management ACGT
Master Ontology
Represent the domain of cancer research and management in a
computationally tractable manner.
1130
Neomark Oral Cancer
Ontology
Describes the medical information necessary for early detection of
the oral cancer reoccurrence.
1686
Upper-Level Cancer
Ontology
Provides  an upper-level ontology for cancer. 3178
NanoParticle Ontology Represents the basic knowledge of physical, chemical and functional
characteristics of nanotechnology as used in cancer diagnosis and
therapy.
1083
Table 5 – Examples of cancer-related ontologies.
Name Description UMLS ID BioPortal ID
Radiology Lexicon A controlled terminology for radiology – a single uniﬁed
source of radiology terms for radiology practice,
education and research.
Not  available 1057
WHO Adverse Reaction Terminology An open-ended terminology for coding of adverse
reaction terms.
WHO  1354
Physician Data Query A part of NCI’s comprehensive cancer information
database, which contains expert summaries on a wide
range of cancer topics, a listing of some 30,000 cancer
clinical trials from around the world, a directory of
genetics services professionals, the NCI Dictionary of
Cancer Terms, and the NCI Drug Dictionary.
PDQ  1349
NCI SEER ICD Neoplasm Code Mappings NCI Surveillance, Epidemiology and End Results (SEER)
conversions between ICD-9-CM and ICD-10 neoplasm
codes.
NCISEER N/A
Table 6 – Examples of cancer reporting systems.
System Body URL Study
CAP Cancer Protocols CAP http://www.cap.org/ [32,64]
TNM UICC http://www.uicc.org/resources/tnm [30,32,65]
BI-RADS ACR http://www.acr.org/Quality-Safety/Resources/BIRADS [14,17–19]
Abbreviations:  ACR, American College of Radiology; CAP, College of American Pathologists; UICC, Union for International Cancer Control.
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Table 7 – Examples of cancer-related information on the web.
Web site URL
Cancer Research UK http://www.cancerresearchuk.org
Centres for Disease Control and Prevention http://www.cdc.gov/DiseasesConditions/az/c.html
MedicineNet.com http://www.medicinenet.com/cancer/focus.htm
MedlinePlus http://www.nlm.nih.gov/medlineplus/cancers.html
National Cancer Institute http://www.cancer.gov/
NHS Cancer Screening Programmes http://www.cancerscreening.nhs.uk/
NHS Choices http://www.nhs.uk/conditions/Cancer
WebMD http://www.webmd.com/cancer/
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f a single prediction: both positive and negative predictions
an be either true or false with respect to the actual labels.
 true positive (TP) is a correct positive prediction, whereas a
rue negative (TN) is a correct negative prediction. Based on two
ypes of errors that may be made by the system, we differenti-
te between a false positive (FP), which is an incorrect positive
rediction, and a false negative (FN), which is an incorrect neg-
tive prediction. In statistics, these errors are referred to as
ype I error and type II error respectively. In case of NER and IE,
he comparison between manually labelled entities and auto-
atically predicted ones can be based on exact matching, in
hich the compared entities must match exactly in order to
e considered correct, and/or partial matching, in which the
ompared entities only need to overlap.
Two measures typically used to evaluate NLP systems are
recision and recall. Precision (P) calculated as TP/(TP + FP) rep-
esents the percentage of positive predictions that are correct.
ecall (R) calculated as TP/(TP + FN) represents the percentage
f positive instances that were predicted as positive and cor-
esponds to the ability to ﬁnd positive instances. Maximising
hese measures is based on optimising two different aspects
f classiﬁcation performance. Reducing the number of type
 errors will increase precision, while reducing the number
f type II errors will increase recall. However, precision and
ecall are naturally opposed in the sense that increasing pre-
ision will typically lead to decreasing recall and vice versa.
herefore, systems will often be compared on how well they
alance precision and recall, which can be estimated using Fˇ
easure calculated as (1 + ˇ2)·P·R/(ˇ2·P + R). The parameter  ˇ is
 non-negative real number used to weigh precision against
ecall in terms of relative importance. The F1 measure (or sim-
ly F measure), which gives no preference to either precision
r recall, is usually reported.
While most NLP systems are evaluated using three mea-
ures (precision, recall and F-measure), the systems reviewed
n this article have been developed with speciﬁc medical appli-
ations in mind. Therefore, the articles describing them often
ontain terminology more  commonly used in medicine (diag-
ostic testing in particular). While we  will be using terms such
s precision and recall hereafter, here we  will map  them to
heir synonyms more  readily understood in the medical com-
unity. Precision is also called positive predictive value, whereas
ecall is typically referred to as sensitivity.  In addition, other
easures motivated by medical applications are used to dis-
uss the performance. Speciﬁcity calculated as TN/(TN + FP)
epresents the percentage of negative instances that were cor-
ectly predicted and corresponds to the ability to avoid falsehttp://www.wcrf-uk.org/
http://www.who.int/cancer/en/
positives, thus complementing recall (i.e. sensitivity). Nega-
tive predictive value calculated as TN/(TN + FN)  represents the
percentage of negative predictions that are correct, thus com-
plementing precision (i.e. positive predictive value). Finally,
accuracy calculated as (TP + TN)/(TP + TN + FP + FN) represents
the percentage of all predictions, either positive or negative,
that are correct.
5.2.  Named  entity  recognition
NER identiﬁes and classiﬁes words and phrases into prede-
ﬁned categories such as diseases, symptoms and drugs. NER
is used mostly as a vehicle for feature extraction in order to
support more  complex NLP tasks such as IE, text classiﬁca-
tion and IR. Most approaches reviewed in this article relied
on dictionary-based NER methods to recognise cancer types
and gene names. The overwhelming majority used MetaMap
to recognise concepts from UMLS [65], usually focusing on spe-
ciﬁc classes (or semantic types as they are called in the UMLS
documentation) of concepts.
The biomedical domain exhibits high degree of termino-
logical variation, which stems from the ability of a natural
language to name a single entity in different ways. It has been
estimated that approximately one third of term occurrences
are variants [66]. The cancer domain is no exception, where
various synonyms for each cancer type exist [67]. For exam-
ple, breast cancer is alternatively referred to as carcinoma of the
breast or mammary neoplasm. The variation phenomenon is fur-
ther magniﬁed by numerous synonyms of associated genes.
For instance, alternative names of breast cancer susceptibility
gene 1 include BRCA1 and its orthographic variants BRCA-1
and BRCA 1 along IRIS, PSCP, BRCAI, BRCC1 or RNF53. Analysis
of text data depends on the ability to automatically recognise
all variants and normalise them by mapping them to a sin-
gle entity they name. Resources that can support this process
include dictionaries with good coverage of alternative names
and explicitly link them together as well as software tools
that can match them ﬂexibly against text, thus allowing for
unforeseen name variants. UMLS described earlier is a com-
prehensive dictionary of biomedical terms organised by their
meaning. In addition, the National Library of Medicine (NLM)
provides MetaMap, a software tool that can annotate UMLS
terms in text and map  them to the corresponding entity [65].
In the previous example it would recognise different ways of
referring to breast cancer in text. Not surprisingly, MetaMap
was used in many  approaches to support recognition of named
entities related to cancer (e.g. [5,30,32,59,68]).
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Kang et al. [69] used MetaMap as a baseline and demon-
strated how its performance on disease names (including
cancers) can be further improved using a rule-based approach.
Dictionary-based NER can only recognise entities if the names
by which they are denoted in text are part of the dictionary.
Kang et al. combined shallow parsing with a number of rules
that adjust noun phrases and feed them back into the nor-
malisation process to check whether they refer to known
entities. Their error analysis highlighted problems associated
with cancer type recognition often due to coordination. Their
approach included coordination resolution in which part-of-
speech and chunking information was used to reformat the
coordination phrase such as colorectal, endometrial and ovar-
ian cancers and recognise ovarian cancers,  colorectal cancers and
endometrial cancers as separate entities. Disease identiﬁcation
improved across all evaluation measures with additional pro-
cessing over MetaMap alone: precision, recall and F-measure
values rose from approximately 55%, 55% and 55–69%, 64% and
66% respectively.
These evaluation results were obtained on the Arizona Dis-
ease Corpus (AZDC), a set of 2856 PubMed abstracts annotated
with disease names mapped to their UMLS identiﬁers [70].
However, most clinical reports are dictated and as such they
naturally contain a higher number of grammatically incorrect
sentences, misspellings, errors in phraseology, transcription
errors, acronyms and abbreviations. Some of these abbrevia-
tions and acronyms tend to be highly idiosyncratic to a speciﬁc
domain as well as local practice, and as such they cannot
always be found in standardised dictionaries such as those
included in UMLS [71]. Nassif et al. [18] illustrated this phe-
nomenon with examples taken from mammography reports.
They based their NER on the BI-RADS lexicon of terms that can
be used to describe ﬁndings in mammograms  (see knowledge
resources above for more  information). The BI-RADS lexicon
differentiates between 43 distinct mammography features.
These features are not uniformly described in mammography
reports, i.e. radiologists often use different terms to refer to the
same concept. Some of these synonyms are explicitly deﬁned
in the lexicon (e.g. equal density and isodense), but others need
to be provided by experts (e.g. oval and ovoid). Additional expert
knowledge can contribute to improve NER performance either
by customising existing lexicons or by supplementing them
with semantic grammars. Nassif et al. implemented a gram-
mar  consisting of rules that specify well-deﬁned semantic
patterns and the underlying BI-RADS categories into which
they are mapped.
More  often, customised or bespoke dictionaries are used to
deal with term variability. For example, the CGMIM system for
mining information about cancers and associated genes con-
siders 21 major cancer types [55]. To deal with the various ways
a given cancer might be referred to in the text (e.g. breast cancer,
breast tumour,  breast carcinoma,  mammary gland tumour, cancer
of the breast,  etc.), they created a list of synonyms for each can-
cer type using the ICD-O and adding familiar lay terminology.
The dictionary would be useful for NER across different can-
cer domains, but the source code does not seem to be available
any longer.
Similarly, Xie et al. performed cancer name recognition
by comparing the text with a cancer name dictionary also
compiled from ICD-O [56]. The cancer classiﬁcation has twoi n f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623
axes: morphology (which describes the form and behaviour
of the tumour) and topology (which describes the site of ori-
gin). A customised dictionary contains a collection of common
names and an ICD-O code that consists of morphology and
topology codes. Additionally, the dictionary includes abbre-
viations for some cancer names, e.g. OSCC was added as a
synonym for oral squamous cell carcinoma.  While the TM results
are publicly available in a database, the dictionary is not read-
ily accessible.
Fang et al. developed a cancer name entity recogniser as
part of their MeInfoText system for mining gene methyla-
tion and cancer association information [72]. They combined
a cancer dictionary and regular expression patterns. The dic-
tionary of cancer names including their abbreviations was
compiled from the previous version of the system [57] (origi-
nally extracted from the Neoplasms by Site (C04.588) section of
the MeSH vocabulary) and public web sites (see in Knowledge
resources above). The patterns used to identify cancer types
were as follows: (1) <abbreviation>, (2) <tumour site> <cancer-
related keyword>, and (3) (.+oma | leukemia | leukaemia).
Abbreviations include acronyms such as NPC (nasopharyngeal
carcinoma) and CRC (colorectal cancer).  Cancer-related keywords
form a specialised lexicon comprised of the following surface
names: cancer,  tumor (tumour), neoplasm, carcinogenesis,  tumori-
genesis and metastasis.  With the exception of abbreviations, the
matching strategies were case-insensitive.
As explained earlier using the work of Kang et al. [69],
dictionary lookup approaches may not be sufﬁcient for NER
regardless of how comprehensive the underlying dictionary
is. While Kang et al. used a rule-based approach to improve a
dictionary-based NER, Jin et al. [73] relied on an ML  approach
to recognise clinical descriptions of malignancy presented in
text. Their software, MTag, applies conditional random ﬁelds
(CRFs) over syntactic and domain-speciﬁc features to extract
strings of text corresponding to a clinician’s or researcher’s ref-
erence to cancer (malignancy type). Malignancy type is deﬁned
here as the full noun phrase encompassing a mention of a
cancer subtype such that neuroblastoma,  localised neuroblastoma
and primary extracranial neuroblastoma are all considered to be
distinct malignant type references. They considered identi-
ﬁcation of all variable descriptions of particular malignant
types, such as squamous cell carcinoma (histological observa-
tion) or lung cancer (anatomical location), both of which are
underspeciﬁed forms of lung squamous cell carcinoma.  MTag was
trained and tested on PubMed abstracts pertaining to cancer
genomics recording precision, recall and F-measure values of
85%, 82% and 83% respectively. Given known issues associ-
ated with processing of clinical text, these values would be
expected to drop, but since the system is based on ML,  it could
be re-trained on a clinical dataset in order to achieve similar
performance in this sublanguage.
Obviously, other named entities apart from cancer types
need to be recognised to support TM of related information,
e.g. drugs, genes, treatments, ﬁndings, anatomical sites, etc.
Dictionaries of these entities can be obtained from specialised
databases and ontologies. For example, RxNorm (a resource
related to UMLS) provides normalised names for clinical drugs
and links them to many  of the drug vocabularies commonly
used in pharmacy management and drug interaction software
[74]. It provides two services: a normalised naming system for
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eneric and branded drugs and a tool for supporting seman-
ic interoperation between drug terminologies and pharmacy
nowledge base systems. In addition to the Gene Ontology
GO) being the standardised representation of gene and gene
roduct attributes across databases [75], gene (and protein)
ame recognition has been a ﬁeld of intense activity in the
ast decade (e.g. [76]) and there is a plethora of tools that can
e readily applied. Information about anatomical entities is
vailable in Foundational Model of Anatomy (FMA) [77], the
ost comprehensive ontology in this domain. It is accessi-
le via BioPortal and is also integrated into UMLS as one of
he source dictionaries. A preliminary investigation suggested
hat anatomical terminology is necessary for modelling cancer
nvasion [23].
For most other named entities, UMLS can be used as a
ocabulary source. Indeed, many  approaches used UMLS to
btain names of relevant entities by focusing on speciﬁc
emantic types. UMLS organises terms into a hierarchy of
ver 130 semantic types, thus grouping named entities into
road categories, which can be used to focus on relevant por-
ions of this comprehensive vocabulary [7]. For example, the
aTIES system for coding and retrieval of surgical pathol-
gy reports and tissue specimens consists of 11 modules,
ne of which is a semantic-type ﬁlter, which removes con-
epts associated with unwanted semantic types following NER
erformed by MetaMap [59]. Heintzelman et al. compiled a dic-
ionary of approximately 675,000 UMLS terms by considering
6 semantic types and utilised it in ClinREAD, a commer-
ial healthcare-oriented rule-based NLP system, to mine pain
nformation in patients with metastatic prostate cancer [37].
arkema et al. used MetaMap to label entities of only three
emantic types (anatomical structure, neoplastic process and sign
r symptom) to support processing of colonoscopy reports [5].
imilarly, Schadow and McDonald used MetaMap to recognise
ntities from 20 semantic types to extract information from
urgical pathology reports [68].
SNOMED CT, which is integrated into UMLS, can be navi-
ated in a similar fashion using its own structure. For example,
he SCENT system relies on a dictionary of approximately
000 clinical entities related to morphology, anatomic site and
rocedural type [21]. To support reasoning about malignancy
tatus based on information contained in pathology reports,
his dictionary was enriched with additional information.
amely, the malignancy potential of each morphology entity
as classiﬁed by up to four physicians with expert pathol-
gy or oncology knowledge. In general, dictionaries used in
ore  speciﬁc approaches focusing on particular cancer type
nd associated clinical procedure are of manageable size and
omplexity and as such may be easily customised in lexical
erms or enriched with additional semantics. For instance,
enny et al. compiled a list of colonoscopy terms, which con-
ists of 26 UMLS concepts related to colonoscopy as well as
ve new terms added as local synonyms for existing UMLS
oncepts (cscopy, C scope, C scopy, cscope and colonscopy)  to sup-
ort processing of non-standardised terminology in medical
otes [25].In summary, MetaMap can be used to effectively identify
MLS terms in text and they can be restricted to semantic
ypes that are relevant for speciﬁc domains and applications.
owever, when bespoke dictionaries need to be utilised, a f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623 613
different dictionary lookup method needs to be used. There
is a wide choice of dictionary lookup tools available many
of which are released as open source (e.g. LINNAEUS [78]),
but before considering their use for clinical cancer applica-
tions, they need to be evaluated in this particular domain.
ConceptMapper by IBM is an open source tool for classify-
ing mentions in text based on standardised or proprietary
terminologies and providing named entities as output [24]. It
can be conﬁgured to use different search strategies or syn-
tactic concepts. ConceptMapper provides similar functionality
and performance to MetaMap without being tied solely to the
UMLS dictionary. Any UIMA-compatible tokeniser can be used
to pre-process both input text and the dictionary content. Con-
ceptMapper then processes input text on a token-by-token
basis, one span (e.g. sentence or noun phrase) at a time. The
process of matching tokens in text against those in dictio-
naries can be customised with respect to case sensitive or
insensitive matching, stemming, abbreviation expansions and
spelling variants. The NER was evaluated in the colon can-
cer domain using related pathology reports obtained from
the Mayo Clinic. Two types of entities were considered for
evaluation: histological diagnoses and anatomical sites. Two
separate dictionaries were initially compiled from ICD-O and
later augmented with synonyms from the UMLS SPECIALIST
Lexicon as well as common abbreviations, adjectival forms
and commonly used shorthand expressions. Different con-
ﬁguration parameters were used in the experiments and
the average values of precision, recall and F-measure were
91%, 88% and 89% for anatomical sites and 86%, 90% and
88% for histological diagnoses, which are relatively high for
dictionary-based NER in clinical text.
5.3.  Information  extraction
IE selects speciﬁc facts about pre-speciﬁed types of enti-
ties and relationships of interest. For example, the 2009 i2b2
medication extraction challenge focused on the extraction of
medication-related information including: medication name
(m), dosage (do), mode (mo), frequency (f), duration (du) and
reason (r) from hospital discharge summaries. In other words,
free-text medical records needed to be converted into a struc-
tured form by ﬁlling a template (a data structure with the
predeﬁned slots) with the relevant information extracted (slot
ﬁllers). In this task, the sentence “In the past two months, she had
been taking Ativan of 3–4 mg q.d. for anxiety.” should be converted
automatically into a structured form as follows [79]:
m=“ativan” || do=“3–4 mg”  || mo=“nm” || f=“q.d.” || du=“two
months” || r=“for anxiety”
where nm indicates that particular information was not men-
tioned. The given example illustrates the need to extract
named entities (e.g. ativan)  as well as quantitative informa-
tion (e.g. dose), but also the extraction of relationships in order
to link the extracted pieces of information to one another.
In the previous section, we have discussed named entities
of relevance in the cancer domain and how they can be
recognised, which would be the ﬁrst step in extracting cancer-
relevant information. The second step requires modelling of
other types of information (e.g. tumour size) and relating
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it to the relevant entities (e.g. where multiple tumours are
mentioned). In this section, we overview the types of cancer-
related information that have been successfully extracted as
well as techniques and approaches used to implement these
IE tasks.
A lot of the extracted information will be speciﬁc to a given
cancer type. For example, pathology reports related to prostate
cancer will typically contain a Gleason score, which a patholo-
gist uses to convey information about the severity of prostate
cancer based on the appearance of cancer cells. The Gleason
grade scale ranges from 1 to 5. Two Gleason values, primary
and secondary, are determined and summed to obtain the
ﬁnal Gleason score, which ranges from 2 (1 + 1) to 10 (5 + 5)
indicating the lowest and highest cancer aggression respec-
tively. Napolitano et al. [36] provided examples of pathology
reports and various ways in which Gleason score is referred to
in text, e.g. “Gleason grades 4 + 4, Gleason score 8”, “Gleason score
8 − 10”,  “Gleason score is 7 (3 + 4)”, “Gleeson grade 3. Total score
6.”, etc. The linear structure of this type of information makes
it amenable to modelling with regular expressions. Indeed,
Napolitano et al. achieved very high recall (98%) and precision
(almost 100%) by taking such a simple approach. The candi-
date text lines were selected using the word Gleason as well as
Gleeson as its common misspelling. The most common textual
patterns used by the pathologist to record the Gleason grades
(G1 and G2) and total score (S) were identiﬁed with some pos-
sible variants, e.g. “Gleason score G1 + G2 = S”, “Gleason score is
G1 + G2 = S”, “Gleason [. . .]  (S) G1 + G2”, etc. The patterns were
coded as regular expressions in Perl and made freely available
at this URL: ftp://ftp.qub.ac.uk/pub/users/gnapolit/perl/. The
potential beneﬁts of this highly reliable approach to extract-
ing cancer staging information are best illustrated with a fact
that manual extraction of Gleason score from a test set of 915
reports was performed in about 30 person-hours as opposed to
around 4 person-hours for coding and ﬁne tuning of extraction
rules followed by negligible processing time.
The same approach was also tested in the skin cancer
domain. Pattern matching rules were implemented to extract
two types of melanoma diagnostic indicators, Breslow depth
and Clark level, from skin biopsy and excision biopsy reports.
The uniform way in which this information is recorded by the
pathologists enabled implementation of a rule-based method
that reached 100% for both precision and recall on a set of 992
reports. These results demonstrated that this approach may
increase the completeness of melanoma staging in Northern
Ireland Cancer Registry by 32% and 18% for Breslow depth and
Clark level respectively.
Similarly, Buckley et al. used commercial NLP software
from ClearForest (a Thomson Reuters company) to demon-
strate how a large body of free text medical information in
breast pathology reports can be converted to a machine read-
able format using NLP [20]. Having an expert read and interpret
each report is an effective but inefﬁcient approach to unlock-
ing the information in free text. It may be suitable in the
day-to-day care of individual patients, but it is impractical on
a large scale or when undertaking retrospective studies. The
goal of this study was to automatically extract information
about pathologic diagnoses from breast pathology reports, i.e.
identify which specimens had evidence of diagnoses of inter-
est: invasive ductal cancer (IDC), invasive lobular cancer (ILC),i n f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623
invasive cancer NOS, ductal carcinoma in situ (DCIS), severe
atypical ductal hyperplasia (severe ADH), lobular carcinoma
in situ (LCIS), atypical lobular hyperplasia (ALH), atypical duc-
tal hyperplasia (ADH) and benign. To deal with the inherent
linguistic and structural variability within free text, a lexi-
con was created for each diagnosis to hold a set of words
and phrases that denote it. For example, the phrases such as
inﬁltrating ductal carcinoma,  invasive cancer with ductal features,
invasive cancer,  ductal type, etc. all went into the invasive ductal
cancer lexicon. Some phrases were built into more  than one
lexicon, e.g. invasive carcinoma with both ductal and lobular fea-
tures was placed in both IDC and ILC lexicons. A signiﬁcant
variability in the way that breast diagnoses can be expressed
was noted. Excluding typographical and spacing errors, Buck-
ley et al. identiﬁed 124 ways of saying invasive ductal cancer,
95 ways of saying invasive lobular cancer and almost 100
ways of referring to four other types of cancer considered.
Lexicons were matched against text to perform NER. As the
ultimate goal was to extract correct diagnoses and not only
their mentions in text, further processing was needed. A diag-
nosis entity may be negated, e.g. a report may state that there
was no evidence of invasive carcinoma or that residual DCIS was
not seen. A pattern-matching approach was used to recog-
nise negation (covering a total of 33 ways in which negation
can be expressed) and remove negated diagnoses from fur-
ther consideration. When multiple diagnoses were present,
then the most signiﬁcant diagnosis was determined based
on the order of signiﬁcance, e.g. IDC, ILC or invasive can-
cer NOS, would outweigh DCIS, which would outweigh severe
ADH, which would outweigh LCIS, which would outweigh ALH,
which would outweigh ADH, which would outweigh benign.
The most signiﬁcant diagnosis was proposed as the primary
diagnosis, whereas the others were listed as secondary diag-
noses. The evaluation on a set of 6711 pathology reports from
three institutions resulted in sensitivity of 99%, speciﬁcity of
96%, positive predictive value of 99% and negative predictive
value of 98%.
Yet another approach used regular expressions to extract
four types of information including tissue type (e.g. liver), site
modiﬁer (e.g. right lobe), collection method (e.g. segmentec-
tomy) and diagnosis (e.g. N4-NX-MX) from surgical pathology
reports [68]. This study hypothesised that surgical pathology
reports would be easier to parse than radiology reports, clini-
cal notes or discharge summaries, because they often conform
to a certain structure that can be exploited in IE. The results
show that automatic coding of targeted information based on
the UMLS identiﬁers was at least sufﬁcient in 90% of cases.
Mamlin et al. demonstrated that coded information can
also be reliably extracted from radiology reports [54]. They
used a commercial system LifeCode [80] by A-Life Medical, Inc.
now OPTUMInsight to code ﬁndings in cancer-related radiol-
ogy reports, i.e. chest X-ray reports, based on ICD-9 and CPT.
The precision and recall achieved on a set of 500 manually
coded reports were 96% and 85% respectively. Their corpus is
available on demand.
Structured information aggregated across different types
of clinical records can support longitudinal analysis of can-
cer status, e.g. to predict survival in metastatic cancer.
Heintzelman et al. used ClinREAD, a commercial healthcare-
domain-oriented, rule-based NLP system by AeroText, to
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xtract pain status from all available paper, electronic, radi-
logic, radiation therapy and pathology records [37]. They
ocused on pain status in particular as it can be used as a
redictor of survival in metastatic prostate cancer and an
ndicator of effectiveness of new therapies. Pain-related infor-
ation included severity, body location and date (start and
nd). Pain status was classiﬁed on a four-tier pain scale: no
ain, some pain, controlled pain and severe pain. With the
verage F-measure of 95% for pain mention detection and 81%
or pain severity classiﬁcation, this study successfully tested
he feasibility of automatically tracking patient pain over time
sing NLP.
Early detection of cancer followed by appropriate treat-
ent signiﬁcantly improves survival rates. Radiologists may
ecommend additional imaging to improve cancer detection,
ut consistency between radiologists with regard to recom-
endation practices for similar patient and clinical attributes,
ncrease or decrease in recommendation rates and patterns
ith evolving technology, type of recommended imaging
echniques and time frames need to be examined in order
o provide radiologists with speciﬁc guidelines for making
ppropriate recommendations. Dang et al. used LEXIMER, a
ommercial system by Nuance, to extract information on rec-
mmendation for additional imaging [81]. Rules were deﬁned
o extract imaging modalities (e.g. MRI, MR  angiography, MR
pectroscopy, etc.), recommendations (e.g. recommend, suggest,
ollow up,  etc.) and time frame (e.g. one year, six weeks,  etc.).
heir approach reached accuracy of 93% for recommended
maging technique and 94% for time frames, thus demonstrat-
ng that accurate determination of recommended imaging
echniques and time frames from radiology reports is possible
ith NLP.
Denny et al. implemented a method to extract similar
ypes of information from EMR  notes [25]. They speciﬁcally
ocused on colonoscopy as a diagnostic procedure for sus-
ected colorectal cancer. Information about time reference
nd colonoscopy status was extracted using a set of linguistic
nd heuristic rules. Heuristics were developed for each status
ype relying on typical phrases as status indicators: scheduling
e.g. referred for,  ordered), considering (e.g. would like to wait),
iscussion (e.g. discussed, explained, recommended), in need of
e.g. due for,  recommended), receipt (e.g. had, underwent)  and
efusal (e.g. refused, declined). Timing references were extracted
t recall of 91% and precision of 95%, colonoscopy status at
ecall 82% and precision of 95%, and colonoscopy completion
t recall of 93% and precision of 95%. The system was later
xtended to extract information about other colorectal cancer
creening methods in addition to colonoscopy: ﬂexible sig-
oidoscopy, faecal occult blood testing and double contrast
arium enema [28]. The average recall and precision were 93%
nd 94%. The NLP method proved superior to the baseline
eﬁned as the associated billing codes explicitly recorded in
he EMRs (44% recall and 83% precision) and as such is a use-
ul adjunct to traditional methods to detect colorectal cancer
creening status.
We conclude this section with an overview of MedTAS/P, a
ystem that extracts complex information to obtain a struc-
ured cancer representation from free-text pathology reports
23]. The system uses a cascade of NLP techniques to populate
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which acts as a detailed template for extraction of cancer-
related information. The main classes and their attributes in
this model are as follows:
1. histology: mention, terminology code
2. anatomical site: mention, terminology code
3. grade: value, scale, type
4. dimension: extent, unit
5. date: day, month, year
6. gross description part: anatomical site, size
7. primary tumour: anatomical site, histology, size, grade
8. metastatic tumour: anatomical site, originating anatomical
site, histology, size, grade
9. lymph node: anatomical site, histology, number of positive
nodes, total number of nodes excised
MedTAS/P performs the usual linguistic pre-processing
including tokenization, sentence discovery, part-of-speech
tagging and shallow parsing. These tools needed to adapt not
only to the medical domain, but to a speciﬁc sub-domain
as well. In particular, the conventions and style of pathol-
ogy reports needed to be taken into account. Errors such as
tagging the word nodes as a verb instead of a noun in the con-
text of lymph nodes propagate through the NLP pipeline and
affect subsequent processing such as NER and relationship
extraction. Therefore, the grammars for general English for the
shallow parser were adapted to reﬂect the syntactic structure
of pathology reports.
Linguistic pre-processing is followed by NER  using the
ICD-O and FMA vocabularies. Cancer-speciﬁc information
(e.g. grade, stage, size, margin, date, tumour blocks, etc.)
is extracted using a combination of rule-based and ML
approaches. Finally, individual results were integrated by
extracting relations between them and were used to populate
the CDKRM.
The system was evaluated on a manually annotated set
of pathology reports of patients diagnosed with colon can-
cer. The best results in terms of F-measure (97–100%) were
achieved for instantiating classes in the CDKRM such as
histologies or anatomical sites. A slightly lower F-measure
(82–93%) was recorded for primary tumours or lymph nodes,
which require the extraction of relations. The lowest F-
measure (65%) was achieved for metastatic tumours, which
was attributed to the small number of cases in the training.
Indeed, other systems such as MEDTEX performed metastasis
classiﬁcation with very high accuracy (94%) [32]. Nonetheless,
MedTAS/P provides an open-source platform which allows for
further improvements and modiﬁcation. The very detailed
cancer representation model can capture cancer disease char-
acteristics in a comparable and consistent fashion. It is
extensible and modiﬁable thus allowing for the model to be
re-used across different cancer domains. The system itself
provides the mappings from free text to the model.
5.4.  Text  classiﬁcationIE converts free text data into structured information, which
adds signiﬁcant value to the data in terms of automated anal-
yses that can then be performed over semantically typed and
structured data. In layman terms, one could view IE as a
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conversion of a Word document into an Excel spreadsheet,
which makes complex statistical calculations only a click
away. However, IE only applies to explicitly stated information.
More  value can be gained by inferring additional informa-
tion that is not explicitly articulated in the original text. This
can be achieved using text classiﬁcation, which uses features
extracted from text (e.g. using NER or more  advanced IE) to
map  text (e.g. sentence, paragraph or most often a whole doc-
ument) into one or more  classes from a predeﬁned scheme.
Using breast cancer as an example, imagine classiﬁcation
of radiology reports into BI-RADS assessment categories: 0
(incomplete), 1 (negative), 2 (benign ﬁnding), 3 (probably
benign), 4 (suspicious abnormality), 5 (highly suggestive of
malignancy), and 6 (known biopsy – proven malignancy). IE
will identify explicitly coded information, but text classiﬁca-
tion will aim to unlock implicitly coded information, making it
amenable to further computational analysis where necessary.
In their early work, Burnside et al. achieved modest results
in terms of precision (83.4 ± 5.3%) and recall (35.4 ± 5.6%) for
classiﬁcation of radiology reports into BI-RADS assessment
categories [14]. They applied the linear least squares ﬁt map-
ping algorithm [82] to very basic features based on word
frequencies and terms from the BI-RADS lexicon. Later, they
implemented a more  advanced method that achieved much
higher values across the three evaluation measures (97.7% pre-
cision, 95.5% recall and 97% F-measure) on the same dataset
[18]. In fact, their automated method outperformed manual
feature extraction (97.5% precision, 89.6% recall and 93% F-
measure) at the 5% statistical signiﬁcance level. Excellent
performance can be attributed to a much richer feature set
based on external knowledge sources such as UMLS as well
as methods more  tuned to this speciﬁc task. They devel-
oped a semantic grammar, which consisted of rules specifying
well-deﬁned semantic patterns and the underlying BI-RADS
categories into which they are mapped.
The NLP system [18] was later utilised for binary classi-
ﬁcation of breast cancer as either invasive or DCIS based on
information contained in mammography reports [19]. The fea-
tures combined coded information (e.g. family breast cancer
history, personal breast cancer history, prior surgery, pal-
pable lump, screening vs. diagnostic, indication for exam,
breast density, BI-RADS code left, BI-RADS code right, BI-
RADS code combined and principal ﬁnding) with information
extracted from free text using NLP (e.g. mass margin, calciﬁca-
tion distribution, mammary  lymph, etc.). They used inductive
logic programming (ILP) to automatically build a classiﬁcation
model expressed as a set of logical if-then rules. If any rule
applies, the model classiﬁes a mammogram instance as a pos-
itive instance (i.e. invasive or DCIS, depending on the model).
If no rule applies, then the model considers the mammogram
instance to be negative (i.e. the alternative class). The beneﬁt
of this approach is that rules are induced automatically from
the data, thus bypassing the knowledge elicitation bottleneck.
Clinician tend to prefer rule-based systems because of their
explanatory power as opposed to alternative ML approaches
(e.g. support vector machines) whose “black box” models do
not provide insight or explanation into the reasons for a par-
ticular classiﬁcation. In this study, an open source ILP engine
Aleph [83] was applied to age-stratiﬁed mammography reports
to build age-speciﬁc classiﬁcation models of invasive versusi n f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623
DCIS cancer occurrence across the strata. An example of a rule
predicting invasive cancer in the younger cohort: The mammo-
gram has a palpable lump in a breast, its breast density is class
2, and its calciﬁcation distribution is not reported. In general, ILP
provided a number of interesting rules, some of which were
previously unreported and worthy of further investigation.
SCENT has been recently developed as a system that com-
bines the functionality of the commercial SAS software with
regular expressions and hierarchical decision rules to clas-
sify pathology reports according to the malignancy status
(benign, borderline, basaloid or malignant) and to classify
malignancy as either primary or recurrent [21]. Malignancy
status was inferred by considering a set of clinical concepts
from SNOMED CT codes related to morphology, anatomic
site and procedural type in a cascade of decision rules.
The malignancy potential of each morphology concept was
previously classiﬁed by up to four physicians with expert
pathology or oncology knowledge. Morphology codes and
anatomic sites consolidated into categories are used to dif-
ferentiate between new primary and recurrent malignancies.
Anatomic site classiﬁcations were consolidated into cate-
gories, e.g. the sternum and clavicle sites belong to the bone
category, sites relating to regional disease spread (e.g. neck and
groin) belong to the lymph nodes category, etc. The system per-
formance was evaluated in two cancer domains. The results
for breast cancer were as follows: sensitivity 93–100%, speci-
ﬁcity 98–100%, positive predictive value 85–98% and negative
predictive value 99–100%; the results in the prostate can-
cer domain were equally good: sensitivity 89–99%, speciﬁcity
98–100%, positive predictive value 89–99% and negative pre-
dictive value 98–100%. The source code should soon become
freely available for non-commercial use and modiﬁcation from
http://www.kp-scalresearch.org/research/tools scent.aspx.
Several other systems have been implemented with a goal
of automatically classifying cancer stage as a richer and more
informative account of disease extent. TNM classiﬁcation of
malignant tumours is an internationally agreed-upon stan-
dard to describe and categorise cancer stages and progression
[62]. It is based on the extent of the primary tumour (T), spread
to nearby lymph nodes (N) and distant metastasis (M):
Primary tumour (T)
• TX: primary tumour cannot be evaluated.
• T0: no evidence of primary tumour.
• Tis: carcinoma in situ.
•  T1, T2, T3, T4: size and/or extent of the primary tumour.
Regional lymph nodes (N)
• NX: regional lymph nodes cannot be evaluated.
• N0: no regional lymph node involvement.
• N1, N2, N3: degree of regional lymph node involvement
(number and location of lymph nodes).
Distant metastasis (M)
• MX: distant metastasis cannot be evaluated.
• M0: no distant metastasis.
• M1: distant metastasis is present.Most cancer types have TNM classiﬁcation and the types
of tests used for staging will depend on the type. In general,
information gathered from physical exams, laboratory tests,
imaging studies, pathology reports and surgical reports will
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e used to determine the stage of a cancer. Several studies
ttempted to automatically produce TNM classiﬁcations from
athology reports [27,30,32,64].
CSIS (Cancer Stage Interpretation System) classiﬁes the
ung cancer stage based on information from pathology
eports across two dimensions of the TNM system, T and N,
ut not M [64]. The system used text classiﬁcation techniques
o train support vector machines (SVMs) to extract elements
f stage listed in cancer staging guidelines (e.g. maximum
umour dimension, visceral pleural invasion, main bronchus
nvasion, chest wall invasion, etc.) and then combined them
nto a global decision. CSIS achieved accuracy of 74% for
umour staging and 87% for node staging.
MEDTEX achieved similar performance in terms of accu-
acy (72%) for tumour staging of lung cancer using a rule-based
ethod [32]. The accuracy for node staging was lower (78%),
ut MEDTEX includes metastasis classiﬁcation at high accu-
acy (94%). The method is based on extracting information
peciﬁed in a relevant CAP electronic Cancer Checklist (see
nowledge resources above), which are subsequently used to
ompute the TNM stage following the logic based on the stag-
ng guidelines. The SNOMED CT encoded version of the CAP
ancer checklist relating to lung cancer resections was used,
hich made a MetaMap a natural choice for ﬁnding relevant
ntities in free text reports.
Martinez et al. experimented with different types of ML
naïve Bayes, SVM, Bayesian network and random forest) to
erform TNM classiﬁcation of colorectal cancer based on
nformation found in histopathology reports [27,30]. The best
esults were achieved with Bayesian methods. The highest F-
easure values for tumour, node and metastasis classiﬁcation
t 64%, 68% and 74% respectively leave room for improvement,
ut do indicate that automatic TNM stage classiﬁcation of col-
rectal cancer is feasible with appropriate feature engineering.
Staying in the colorectal cancer domain, Harkema et al.
emonstrated that the information required for colonoscopy
uality measures such as “If indication is chronic diarrhoea,
btain biopsy” is amenable to automatic extraction from free-
ext colonoscopy and pathology reports [5]. Their NLP system
xtracted the values of the 21 necessary variables (e.g. indi-
ation type, biopsy, etc.) with an average accuracy of 89% and
verage F-measure of 74%, which imply that the NLP-derived
utcomes for these quality measures can be practically use-
ul for quality reporting. Moreover, with further reﬁnement
nd development the NLP system could be employed for rou-
ine quality measurement on a large scale. At the moment,
he values of the target variables are established using gener-
lly simple rules, e.g. if a concept colon cancer with contextual
roperties directionality = afﬁrmed, temporality = historical, and
xperiencer = family member has been identiﬁed within a report,
hen the variable family history is set to present,  whereas tem-
oral expressions and size measurements are parsed and
nterpreted with a set of regular expressions.
In another rule-based approach, Wagholikar et al. relied
n NLP to implement a clinical decision support system
CDSS) for colonoscopy surveillance using information found
n pathology reports, procedure notes and the indications for
olonoscopy [29]. This work was based on the premises that
he guidelines for colonoscopy surveillance were comprehen-
ive to address all possible patient scenarios and that the f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623 617
relevant patient information in the free text reports could
be accurately extracted with NLP. Guidelines for colonoscopy
surveillance were converted into a ﬂowchart, which was
implemented as set of 172 if-then rules that represented 43
nodes and 88 edges from the ﬂowchart. The text processor
was based on dictionaries, word patterns, and hand-coded
rules to map  the word patterns to parameter values of inter-
est. Additional knowledge was elicited from pathologists and
physicians, and coded into rules in order to interpret implicit
information in text documents, e.g. if the pathologist does
not mention a ﬁnding of cancer, the referring physician can
interpret that there was no ﬁnding of cancer. All rules were
combined in a binary classiﬁer that outputs a decision for
colonoscopy. Manual evaluation revealed that in 45 of 53 cases,
the recommendation of the CDSS matched with the initial
recommendation of the gastroenterologist; in ﬁve cases the
gastroenterologist retained her initial recommendation, as
the CDSS recommendation was not optimal; in three cases
the CDSS helped the gastroenterologist to revise her initial
blinded recommendations. Overall, the results demonstrated
NLP can be effectively coupled with clinical decision support to
improve colonoscopy surveillance for prevention of colorectal
cancer.
Similarly, the results of the iDiagnosis system can be used
to recommend screening for those at higher risk of pancreatic
cancer automatically detected from EMR data [34]. Knowledge
extracted from PubMed and EMRs semi-automatically was
used to inform a prediction model. Variables of the model fall
into ﬁve categories (demographics, life style, symptoms, co-
morbidities and lab test results) and were selected based on a
literature review, the recommendations by clinical experts and
risk factors previously identiﬁed by the authors. All 20 vari-
ables were available in EMRs, but half of them could only be
found in narrative notes and were searched using the MedLEE
system [84]. All variables were weighted based on their associ-
ations with pancreatic cancer mined from PubMed. Keywords
were used to indicate the polarity of each co-occurrence: posi-
tive (e.g. risk, link, etc.), negative (e.g. comparison,  discrimination,
etc.) or neutral (e.g. equal to, same to,  etc.). The ratio between
positive and negative associations was treated as a statisti-
cal summary of the collective evidence for the association
between a risk factor and pancreatic cancer. Prior probability
for each variable, e.g. P(alcohol or cigarette abuse = true | pan-
creatic cancer = true), was calculated using the EMR  data. The
weights and prior probabilities were then incorporated into
the Bayesian Network Inference (BNI) model, from which the
posterior probabilities, e.g. P(pancreatic cancer = true | alcohol
or cigarette abuse = true), can be calculated and used for dis-
ease prediction. With sensitivity, speciﬁcity and accuracy of
85%, the BNI method signiﬁcantly outperformed an SVM used
as a baseline, which achieved 77% sensitivity, 40% speciﬁcity
and 53% accuracy. This indicates that the choice of classiﬁca-
tion method largely depends on the dimensionality of feature
space. SVM methods excel primarily in a high-dimensional
feature space, whereas the BNI model performs well in a low-
dimensional feature space.A range of ML classiﬁers were studied for the classiﬁcation
of cancer-related death certiﬁcates: SVM, multinomial naïve
Bayes, C4.5 and adaptive boosting [45]. Numerous features
were used including stemmed words, bi-grams and SNOMED
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CT terms, which were extracted with the MEDTEX toolkit [32].
An SVM classiﬁer achieved the best F-measure of almost 99%
when evaluated on a set of 5000 free text death certiﬁcates.
The SVM classiﬁer used with different features accounted for
the top 18 of 40 evaluated runs and had the lowest variance,
making it the most robust classiﬁer for the task. The selec-
tion of features signiﬁcantly inﬂuenced the performance of the
classiﬁers. Stemmed tokens arose as the single most impor-
tant feature set among those considered. The study found
that SNOMED CT features provided consistent increments in
classiﬁcation robustness if used along with stemmed tokens.
Stemmed tokens combined with their TF-IDF score (a mea-
sure typically used in IR) also proved to be good features
for classiﬁcation of risk types of each human papillomavirus
(HPV) based on their textual explanation in the HPV Sequence
Database [41]. The database contains a complete list of
papillomavirus types and hosts and the records for each
unique papillomavirus [85]. Human papillomavirus infection
is known as the main factor for cervical cancer, a leading
cause of cancer deaths in women. With more  than 100 types
of HPVs it is critical to discriminate between those related
with cervical cancer and those that are not. Each HPV type
was represented as a vector whose elements were TF-IDF of
1434 stemmed tokens remaining after removing stop words.
Three ML  approaches were used: naïve Bayes, adaptive boost-
ing and its variant AdaCost, a misclassiﬁcation cost-sensitive
boosting method. The latter performed best with accuracy of
93% and F-measure of 86%, thus implying that most high-risk
HPVs were identiﬁed.
5.5.  Information  retrieval
IR can be viewed as a classiﬁcation problem in which each
document is classiﬁed as either relevant or irrelevant for the
user’s information need expressed with a search query. It is
the necessary ﬁrst step in gathering relevant data from a
larger collection such as EMRs. Translational research requires
detailed clinical information such as disease stage, disease
severity and response to treatment to identify relevant cases
and perform correlative studies. However, most clinical out-
come information is stored as free text rather than coded,
structured data. The caTIES system was implemented to
make unstructured clinical information in surgical pathology
reports more  readily accessible for translation research [59]. It
creates a text search engine index for fast access to documents
based on text characteristics and conceptual codes and also
maintains an ancestor index that associates NCI Thesaurus
concepts with their ancestry. caTIES supports both query by
text and query by concept. Queries can be constrained by
demographic variables such as age and gender. Boolean oper-
ators AND, OR and NOT can be used to combine search terms
and constraints. Additionally, temporal queries based on the
timing of diagnostic reports are allowed, e.g. “Find all females
who had lobular carcinoma in situ, followed by mastectomy within
1 year.”
The precision of the caTIES system was 94–96% for simple
and moderately complex queries, while it dropped down to
88% for more  complex temporal queries. Most common errors
referred to retrieval of documents in which the search concept
was erroneously coded by the system because a substring ofi n f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623
the more  complex concept was recognised by MetaMap, e.g.
report for post-mastectomy scar retrieved for query mastectomy.
These errors often occur because the more  complex concepts
are post-coordinated concepts and are not represented in the
dictionary. This emphasises the importance of NER perfor-
mance in subsequent text processing. The previous section
on NER provides descriptions of some approaches to dealing
with these problems.
Another common source of errors was an incorrect clin-
ical diagnosis, where specimen was labelled with a clinical
diagnosis, which was subsequently corrected by pathologi-
cal examination. Similarly, diagnostic uncertainty (e.g. cannot
exclude) was a common problem in retrieving clinical doc-
uments. Other error categories observed include initials
incorrectly coded as abbreviations (e.g. report with initials HL
retrieved for query Hodgkin’s lymphoma),  concepts identiﬁed
in the report that are in fact historical (e.g. report describing
previous history of renal cell carcinoma retrieved for query renal
cell carcinoma),  conceptual relationships not properly scoped
(e.g. report containing prostate cancer without perineural inva-
sion, and urothelial cancer with perineural invasion is returned for
query prostate cancer with perineural invasion), errors in nega-
tion detection (e.g. neither prostatic intraepithelial carcinoma nor
carcinoma is seen is returned for query containing prostatic
intraepithelial carcinoma).  Most of the observed errors could be
eliminated by limiting search to speciﬁc report sections and by
extending the negation detection to account for uncertainty.
The caTIES system is freely available under an open source
licence.
Evaluation of another clinical retrieval system, ARC [26],
showed variation across three cancer domains: colorectal,
prostate and lung cancer. The data used for evaluation
included imaging reports (X-rays, CT scans and MRI) con-
sistent with lung cancer, pathology reports consistent with
colorectal cancer and pathology reports consistent with
prostate cancer. Recall, precision and F-measure were 90%,
92% and 89% for colorectal cancer, 97%, 95% and 94% for
prostate cancer and signiﬁcantly lower at 76%, 80% and 75%
for lung cancer. This is not necessarily the reﬂection of the
language variability across the three domains, but rather the
type of information contained in different types of reports.
The pathology report is the primary document for recording
a diagnosis of prostate cancer and colorectal. However, lung
cancer diagnosis is usually determined by a combination of
imaging studies, biopsies and laboratory results. Despite the
variability in the results, this study demonstrated that the
ARC system with no custom software or rules development
is sufﬁciently generalisable across different cancer domains.
The ARC system is also freely available under an open source
licence.
We will end this section and the review of different NLP
tasks in the cancer domain by relating it back to patients.
Bader and Theofanos analysed cancer-related queries on
Ask.com, a search engine which allows users to create queries
using whole phrases and sentences of any length rather than
just key words [86]. Over 78% of sampled queries referred to
14 cancer types. The most-common cancer types mentioned
in queries were digestive/gastrointestinal/bowel (15%), breast
(12%), skin (11%) and genitourinary (11%). Queries were sorted
into cancer-related categories including general information,
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ymptoms, diagnosis and testing, treatment, statistics, def-
nition and cause/risk/link. Additional categories of queries
bout speciﬁc cancer types varied. This study highlighted the
peciﬁc needs of patients and general-public users, what they
eally want to know about cancer, how they phrase their ques-
ions and how much detail they use. These results obtained
ith NLP can help healthcare providers improve the way
n which they communicate cancer-related information to
atients.
.  Text  mining  systems
 table in the Supplementary material provides a summary of
he systems described in this section focusing on particular
LP tasks: named entity recognition, information extraction,
ext classiﬁcation and information retrieval. Here we provide a
ore detailed overview of two more  generic NLP systems that
ave been developed for and/or tested in the cancer domain.
.1.  MedLEE
he goal of the MedLEE (Medical Language Extraction and
ncoding) system, developed at Columbia University in col-
aboration with the City University of New York, is to extract,
tructure and encode clinical information in free text patient
eports so that it can be further exploited by subsequent auto-
ated processes. Originally, MedLEE was designed to process
adiological reports of the chest to detect patients suspicious
or tuberculosis [84]. MedLEE has since been extended to cover
ll of radiology and also pathology, echocardiology, electrocar-
iography and hospital discharge summaries [87]. Being tuned
or processing radiology and pathology reports makes MedLEE
irectly relevant for the cancer domain. In particular, MedLEE
as used to mine breast cancer information from surgical
athology reports [16] as well as mammogram reports [88]. It
as also applied to process 889,921 chest radiographic reports
n order to extract information about 24 medical conditions
ncluding lung cancer [31].
MedLEE consists of the following modules: pre-processor,
arser, phrase regularisation and encoding. Pre-processor
egments the text into sections, paragraphs, sentences and
ords. It then performs NER by dictionary lookup, handles
bbreviations using a mapping table, and performs some word
ense disambiguation based on contextual rules. The initial
uning of MedLEE for a speciﬁc cancer domain would apply to
hese elements, i.e. lexicons, tables and contextual rules.
The parser determines the structure of each sentence using
 grammar that consists of syntactic and semantic rules. Fol-
owing the parsing stage, the phrases are regularised in order
o normalise the representation of their meaning. One aspect
f phrase regularisation involves using domain knowledge to
dd information to the output that is implicit in the domain.
or example, infarct implies myocardial infarction in cardiol-
gy reports, but could refer to another body location in other
ypes of reports (e.g. pulmonary infarction). The domain knowl-
dge is speciﬁed in a table created manually using domain
xpertise, so it would require knowledge elicitation in order to
odel different cancer domains. Encoding uses another table
o add codes (e.g. UMLS) to words and regularised phrases. f o r m a t i c s 8 3 ( 2 0 1 4 ) 605–623 619
This means that tables can be created to enable the use of dif-
ferent coding systems. The section on Knowledge sources lists
coding systems relevant to cancer that can be utilised in this
module.
We will use two case studies to illustrate how well MedLEE
can perform in cancer domains. Hripcsak et al. performed
internal and external validation to investigate the accuracy
of NLP for translating chest radiographic narrative reports
into a large database [31]. MedLEE was used to code 889,921
reports on 251,186 patients. Using a set of 150 manually coded
reports as a gold standard, sensitivity of 81% and speciﬁcity
of 99% were reported. A total of 24 clinical conditions (dis-
eases, abnormalities and clinical states) were the subject of
this study. We believe that focusing on lung cancer alone
would allow for ﬁner tuning of the underlying lexical and
domain-speciﬁc knowledge, which would be reﬂected in better
sensitivity.
In another study MedLEE was extended to better deal with
breast cancer information found in surgical pathology reports
[16]. Targeted information included procedure name, number
of positive lymph nodes, expression of oestrogen receptors,
progesterone receptors and Her-2/Neu, nuclear grade, ploidy,
DNA index, quantitative S-Phase, qualitative S-Phase, G2-M
and proliferation Index. A relatively small number of man-
ually annotated documents were used for development (20)
and testing (50). High values for sensitivity (91%) and preci-
sion (92%) were recorded. However, performance was much
better for the tabular ﬁndings (sensitivity of 96% and preci-
sion of 95%) than for narrative ﬁndings (sensitivity of 86% and
precision of 88%).
6.2.  cTAKES
cTAKES (clinical Text Analysis and Knowledge Extraction
System), a generic NLP system developed at the Mayo Clinic,
is tailored to the clinical domain and can add rich linguistic
and semantic annotations to the narrative found in EMRs [89].
It has been designed to be scalable, comprehensive, modular,
extensible and robust to meet the rigours of clinical research.
cTAKES consists of the following NLP modules: sentence
boundary detector, tokenizer, normalizer, POS tagger, shallow
parser and NER annotator (including status and negation
annotators). The performance of individual components was
evaluated on a clinical corpus sampled from the Mayo Clinic
EMRs. Sentence boundary detection was performed with
an accuracy of 95%. Tokenizer achieved the same accuracy
with part-of-speech tagger accuracy only slightly lower at
94%. The shallow parser achieved an F-measure of 93%.
NER performance (F-measure of 72% for exact matching and
82% for non-exact matching) could be improved with richer
dictionaries and additional post-processing. Negation and
status attributes of named entities were extracted with an
F-measure of 96% and 94% respectively. A global system evalu-
ation of cTAKES for patient cohort identiﬁcation for 25 clinical
research studies has been conducted. The system was also
used for treatment classiﬁcation for a pharmacogenomics
breast cancer treatment study. The cTAKES named entity
attributes are similar to those in MedLEE. Unlike MedLEE, the
cTAKES currently does not assert relationships between a dis-
ease/disorder, sign/symptom or procedure and an anatomical
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site. However, MedLEE is a patented system and is undergoing
commercialization via Health Fidelity, Inc., who were given
exclusive rights to its portfolio of patents, software code and
trademarks. In contrast, cTAKES has been released under a
free software licence and thus can be readily used to support
NLP applications for cancer but can also be further modiﬁed
to better address speciﬁc tasks in this domain. It is available
for download from http://ctakes.apache.org/.
7.  Discussion  and  conclusions
In this article, we have reviewed current TM approaches
with clinical applications in the cancer domain. The review
highlighted a strong bias towards symbolic methods, e.g. NER
largely based on dictionary lookup and IE relying on pattern
matching. While these can be regarded as more  conservative
approaches to TM,  they nonetheless deliver good perfor-
mance. The F-measure of NER ranges between 80% and 90%
(e.g. [73]), while that of IE for simple tasks is in the high 90s
(e.g. [36]). This can be explained by the relative stability of the
clinical sublanguage in this particular domain in comparison
to biology, where dictionaries quickly become out of date,
so ML  approaches such as CRFs are more  commonly used
for NER (e.g. [90]). The comparatively slower dynamics of the
clinical cancer domain allows for dictionaries to be updated
manually when new concepts such as drugs, diagnostic tests
and related genes are identiﬁed. However, the fact that clinical
concept names vary considerably due to idiosyncrasies of the
clinical sublanguage such as non-standard abbreviations (e.g.
cscopy, C scopy are used as synonyms of colonoscopy) can be
attributed to NER relying on standard dictionaries (e.g. UMLS)
and tools (e.g. MetaMap) not performing better than 90% in
terms of F-measure.
The relatively limited domain scope still allows for manual
extension of dictionaries with non-standard terminology
(e.g. [21]), but the problems associated with the clinical
sublanguage such as high degree of spelling and grammatical
errors calls for a more  general and robust approach to NER. To
account for syntactic variation, Kang et al. [69] demonstrated
how a rule-based approach mapping between the shallow
parses and MetaMap outputs can improve the results of NER.
Our investigation into automatic term recognition revealed
that most syntactic, morphological and orthographic varia-
tions can be identiﬁed by simply ignoring the internal phrase
structure in a bag-of-words approach and using phonetic and
edit distance algorithms to map  between individual tokens
[91]. We, therefore, suggest that such an approach can be used
to improve the performance of dictionary-based NER in order
to effectively deal with both syntactic variation and spelling
errors.
Nonetheless, there remains a need for a comprehensive
cancer ontology that would include rich terminologies for
each cancer type as well as relationships to other relevant
concepts (e.g. screening and treatment methods, synoptic
reporting formats, checklists, etc.). The ontology should be
an open community effort allowing seamless integration of
internally developed terminologies, which currently are either
not shared at all (e.g. [56]) or remain conﬁned to supplemen-
tary materials (e.g. [25]) in non-standardised formats. The
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of bespoke ontologies (e.g. [22]) and representation models
(e.g. [23]) would allow more  resources for development of the
actual TM methods. Sharing the ontology in community por-
tals comes with the beneﬁt of readily available web services
(e.g. [61,92]) that would automatically provide programmatic
access to the ontology, which would allow easy integration
into the TM framework [93].
Most IE systems reviewed here are rule-based. For sim-
ple types of information, such methods are fast and easy to
develop and they perform extremely well (e.g. [36]). However,
for more  complex and variable types of information, ML  may
be necessary. A range of synoptic reporting formats available
for different types of cancer [4] clearly indicate what informa-
tion should be targeted by future IE systems. Synoptic formats
can act as IE templates. Where synoptic reports are already
used in clinical practice, their content can be used to train the
IE systems.
The extent to which ML will be incorporated into IE system
will undoubtedly be limited by strong preference for rule-
based systems over “black box” ML models in clinical practice.
Some ML approaches will be more  acceptable than others. For
example, approaches such as ILP can be used to induce rules,
thus effectively addressing the knowledge elicitation bottle-
neck associated with rule-based systems while still beneﬁting
from the explanatory power of rules (e.g. [18]). In many  cases,
the reporting guidelines such as those for TNM staging will
readily provide the classiﬁcation rules, hence the need for ML
may be conﬁned to extracting the relevant information not
necessarily classiﬁcation itself.
Narrative reports such as pathology and radiology reports
convey valuable diagnostic information that is predictive
of the prognosis and biological behaviour of a disease pro-
cess [63]. A range of studies have proven the feasibility of
NLP for structuring free text reports (e.g. [16,20,23,27,94]).
Evaluations of NLP systems suggest that they can provide
accurate data on service provision and patient clinical status
[95]. In some cases, NLP results were superior to formally
coded information in EMRs (e.g. [25]), which opens a range
of possible applications in clinical practice. Indeed, many
NLP approaches have been developed with direct clinical
applications for cancer monitoring and prevention in mind.
For example, two studies have shown that NLP can be coupled
with clinical decision support in order to improve colorectal
cancer screening rates [25,29]. Unfortunately, the actual pro-
cedures for colorectal cancer screening are often inadequate
and vary widely among physicians, but NLP can support
routine measurement of colonoscopy quality [5]. Similarly,
NLP was applied to radiology reports to investigate additional
imaging recommendation practice as this task requires
careful balance between healthcare cost and accuracy and
timeliness of cancer diagnosis [81]. Most often, NLP was used
for predictive modelling of cancer that can be used to inform
clinical decision making. Examples include prediction of
invasive cancer across different age cohorts [19], risk of malig-
nancy of breast cancer [17], risk of pancreatic cancer [34], lung
cancer stage [32], survival in metastatic prostate cancer [37],
etc. Most of these NLP systems have been developed and used
locally due to strict legal regulations, which make healthcare
institutions reluctant to share free-text medical reports
even when all reasonable measures to protect privacy and
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Summary points
What was already known before this study:
• Narrative reports such as pathology or radiology
reports convey valuable diagnostic information that
can be used for predictive modelling of cancer.
• Individual studies have proven the feasibility of
speciﬁc NLP techniques for extracting structured infor-
mation from free text reports.
What this study has added to our knowledge:
• An overview of available knowledge sources that can
support semantic interpretation of clinical narratives
related to cancer.
• An overview of available methods and techniques used
for TM of clinical narratives related to cancer.
• The ﬁnding that ML  approaches have not been fully
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rexplored in TM of cancer-related information.
onﬁdentiality are taken (e.g. de-identiﬁcation and data use
greements) [51]. More  widely, this issue remains the main
ottleneck for progress in healthcare applications of NLP.
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